Selected research
Industry Research
Human Recombinant SCF Industry Research Report 2026
Market perspective
The global Human Recombinant SCF market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Human Recombinant SCF is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Human Recombinant SCF is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Human Recombinant SCF is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Human Recombinant SCF include Thermo Fisher Scientific Inc., Sino Biological, STEMCELL Technologies, SigmaAldrich, R&D Systems, Qkine, Proteintech Group, Inc, Prospec and Miltenyi Biotec, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Human Recombinant SCF market in terms of revenue (US$ million) and, where applicable, sales volume (kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Human Recombinant SCF Market by Company
Thermo Fisher Scientific Inc.
Sino Biological
STEMCELL Technologies
SigmaAldrich
R&D Systems
Qkine
Proteintech Group, Inc
Prospec
Miltenyi Biotec
Kingfisher Biotech, Inc.
FUJIFILM Irvine Scientific
Cell Signaling Technology
Applied Biological Materials (abm) Inc
AJINOMOTO
Abcam
Human Recombinant SCF Segment by Type
Native-like Human Recombinant SCF
Modified Human Recombinant SCF
Human Recombinant SCF Segment by Application
Medical
Biological Research
Human Recombinant SCF Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Recombinant SCF market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Recombinant SCF and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Recombinant SCF.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Human Recombinant SCF manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Human Recombinant SCF by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Human Recombinant SCF in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Native-like Human Recombinant SCF
- Modified Human Recombinant SCF
Applications
- Medical
- Biological Research
Companies covered
- Thermo Fisher Scientific Inc.
- Sino Biological
- STEMCELL Technologies
- SigmaAldrich
- R&D Systems
- Qkine
- Proteintech Group, Inc
- Prospec
- Miltenyi Biotec
- Kingfisher Biotech, Inc.
- FUJIFILM Irvine Scientific
- Cell Signaling Technology
- Applied Biological Materials (abm) Inc
- AJINOMOTO
- Abcam
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Human Recombinant SCF Market Size (2021-2032)
- 2.2.2 Global Human Recombinant SCF Sales (2021-2032)
- 2.2.3 Global Human Recombinant SCF Market Average Price (2021-2032)
- 2.3 Human Recombinant SCF by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Native-like Human Recombinant SCF
- 2.3.3 Modified Human Recombinant SCF
- 2.4 Human Recombinant SCF by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Medical
- 2.4.3 Biological Research
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Human Recombinant SCF Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Human Recombinant SCF Sales (kg) of Manufacturers (2021-2026)
- 3.3 Global Human Recombinant SCF Revenue of Manufacturers (2021-2026)
- 3.4 Global Human Recombinant SCF Average Price by Manufacturers (2021-2026)
- 3.5 Global Human Recombinant SCF Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Human Recombinant SCF, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Human Recombinant SCF, Product Type & Application
- 3.8 Global Manufacturers of Human Recombinant SCF, Established Date
- 3.9 Global Human Recombinant SCF Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Thermo Fisher Scientific Inc.
- 4.1.1 Thermo Fisher Scientific Inc. Company Information
- 4.1.2 Thermo Fisher Scientific Inc. Business Overview
- 4.1.3 Thermo Fisher Scientific Inc. Human Recombinant SCF Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Thermo Fisher Scientific Inc. Human Recombinant SCF Product Portfolio
- 4.1.5 Thermo Fisher Scientific Inc. Recent Developments
- 4.2 Sino Biological
- 4.2.1 Sino Biological Company Information
- 4.2.2 Sino Biological Business Overview
- 4.2.3 Sino Biological Human Recombinant SCF Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sino Biological Human Recombinant SCF Product Portfolio
- 4.2.5 Sino Biological Recent Developments
- 4.3 STEMCELL Technologies
- 4.3.1 STEMCELL Technologies Company Information
- 4.3.2 STEMCELL Technologies Business Overview
- 4.3.3 STEMCELL Technologies Human Recombinant SCF Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 STEMCELL Technologies Human Recombinant SCF Product Portfolio
- 4.3.5 STEMCELL Technologies Recent Developments
- 4.4 SigmaAldrich
- 4.4.1 SigmaAldrich Company Information
- 4.4.2 SigmaAldrich Business Overview
- 4.4.3 SigmaAldrich Human Recombinant SCF Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 SigmaAldrich Human Recombinant SCF Product Portfolio
- 4.4.5 SigmaAldrich Recent Developments
- 4.5 R&D Systems
- 4.5.1 R&D Systems Company Information
- 4.5.2 R&D Systems Business Overview
- 4.5.3 R&D Systems Human Recombinant SCF Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 R&D Systems Human Recombinant SCF Product Portfolio
- 4.5.5 R&D Systems Recent Developments
- 4.6 Qkine
- 4.6.1 Qkine Company Information
- 4.6.2 Qkine Business Overview
- 4.6.3 Qkine Human Recombinant SCF Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Qkine Human Recombinant SCF Product Portfolio
- 4.6.5 Qkine Recent Developments
- 4.7 Proteintech Group, Inc
- 4.7.1 Proteintech Group, Inc Company Information
- 4.7.2 Proteintech Group, Inc Business Overview
- 4.7.3 Proteintech Group, Inc Human Recombinant SCF Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Proteintech Group, Inc Human Recombinant SCF Product Portfolio
- 4.7.5 Proteintech Group, Inc Recent Developments
- 4.8 Prospec
- 4.8.1 Prospec Company Information
- 4.8.2 Prospec Business Overview
- 4.8.3 Prospec Human Recombinant SCF Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Prospec Human Recombinant SCF Product Portfolio
- 4.8.5 Prospec Recent Developments
- 4.9 Miltenyi Biotec
- 4.9.1 Miltenyi Biotec Company Information
- 4.9.2 Miltenyi Biotec Business Overview
- 4.9.3 Miltenyi Biotec Human Recombinant SCF Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Miltenyi Biotec Human Recombinant SCF Product Portfolio
- 4.9.5 Miltenyi Biotec Recent Developments
- 4.10 Kingfisher Biotech, Inc.
- 4.10.1 Kingfisher Biotech, Inc. Company Information
- 4.10.2 Kingfisher Biotech, Inc. Business Overview
- 4.10.3 Kingfisher Biotech, Inc. Human Recombinant SCF Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Kingfisher Biotech, Inc. Human Recombinant SCF Product Portfolio
- 4.10.5 Kingfisher Biotech, Inc. Recent Developments
- 4.11 FUJIFILM Irvine Scientific
- 4.11.1 FUJIFILM Irvine Scientific Company Information
- 4.11.2 FUJIFILM Irvine Scientific Business Overview
- 4.11.3 FUJIFILM Irvine Scientific Human Recombinant SCF Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 FUJIFILM Irvine Scientific Human Recombinant SCF Product Portfolio
- 4.11.5 FUJIFILM Irvine Scientific Recent Developments
- 4.12 Cell Signaling Technology
- 4.12.1 Cell Signaling Technology Company Information
- 4.12.2 Cell Signaling Technology Business Overview
- 4.12.3 Cell Signaling Technology Human Recombinant SCF Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Cell Signaling Technology Human Recombinant SCF Product Portfolio
- 4.12.5 Cell Signaling Technology Recent Developments
- 4.13 Applied Biological Materials (abm) Inc
- 4.13.1 Applied Biological Materials (abm) Inc Company Information
- 4.13.2 Applied Biological Materials (abm) Inc Business Overview
- 4.13.3 Applied Biological Materials (abm) Inc Human Recombinant SCF Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Applied Biological Materials (abm) Inc Human Recombinant SCF Product Portfolio
- 4.13.5 Applied Biological Materials (abm) Inc Recent Developments
- 4.14 AJINOMOTO
- 4.14.1 AJINOMOTO Company Information
- 4.14.2 AJINOMOTO Business Overview
- 4.14.3 AJINOMOTO Human Recombinant SCF Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 AJINOMOTO Human Recombinant SCF Product Portfolio
- 4.14.5 AJINOMOTO Recent Developments
- 4.15 Abcam
- 4.15.1 Abcam Company Information
- 4.15.2 Abcam Business Overview
- 4.15.3 Abcam Human Recombinant SCF Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Abcam Human Recombinant SCF Product Portfolio
- 4.15.5 Abcam Recent Developments
5 Global Human Recombinant SCF Market Scenario by Region
- 5.1 Global Human Recombinant SCF Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Human Recombinant SCF Sales by Region: 2021-2032
- 5.2.1 Global Human Recombinant SCF Sales by Region: 2021-2026
- 5.2.2 Global Human Recombinant SCF Sales by Region: 2027-2032
- 5.3 Global Human Recombinant SCF Revenue by Region: 2021-2032
- 5.3.1 Global Human Recombinant SCF Revenue by Region: 2021-2026
- 5.3.2 Global Human Recombinant SCF Revenue by Region: 2027-2032
- 5.4 North America Human Recombinant SCF Market Facts & Figures by Country
- 5.4.1 North America Human Recombinant SCF Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Human Recombinant SCF Sales by Country (2021-2032)
- 5.4.3 North America Human Recombinant SCF Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Human Recombinant SCF Market Facts & Figures by Country
- 5.5.1 Europe Human Recombinant SCF Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Human Recombinant SCF Sales by Country (2021-2032)
- 5.5.3 Europe Human Recombinant SCF Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Human Recombinant SCF Market Facts & Figures by Country
- 5.6.1 Asia Pacific Human Recombinant SCF Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Human Recombinant SCF Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Human Recombinant SCF Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Human Recombinant SCF Market Facts & Figures by Country
- 5.7.1 South America Human Recombinant SCF Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Human Recombinant SCF Sales by Country (2021-2032)
- 5.7.3 South America Human Recombinant SCF Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Human Recombinant SCF Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Human Recombinant SCF Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Human Recombinant SCF Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Human Recombinant SCF Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Human Recombinant SCF Sales by Type (2021-2032)
- 6.1.1 Global Human Recombinant SCF Sales by Type (2021-2032) & (kg)
- 6.1.2 Global Human Recombinant SCF Sales Market Share by Type (2021-2032)
- 6.2 Global Human Recombinant SCF Revenue by Type (2021-2032)
- 6.2.1 Global Human Recombinant SCF Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Human Recombinant SCF Revenue Market Share by Type (2021-2032)
- 6.3 Global Human Recombinant SCF Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Human Recombinant SCF Sales by Application (2021-2032)
- 7.1.1 Global Human Recombinant SCF Sales by Application (2021-2032) & (kg)
- 7.1.2 Global Human Recombinant SCF Sales Market Share by Application (2021-2032)
- 7.2 Global Human Recombinant SCF Revenue by Application (2021-2032)
- 7.2.1 Global Human Recombinant SCF Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Human Recombinant SCF Revenue Market Share by Application (2021-2032)
- 7.3 Global Human Recombinant SCF Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Human Recombinant SCF Value Chain Analysis
- 8.1.1 Human Recombinant SCF Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Human Recombinant SCF Production Mode & Process
- 8.2 Human Recombinant SCF Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Human Recombinant SCF Distributors
- 8.2.3 Human Recombinant SCF Customers
9 Global Human Recombinant SCF Analyzing Market Dynamics
- 9.1 Human Recombinant SCF Industry Trends
- 9.2 Human Recombinant SCF Industry Drivers
- 9.3 Human Recombinant SCF Industry Opportunities and Challenges
- 9.4 Human Recombinant SCF Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst